Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination
Franziska Neumann, Ruben Rose, Janine Römpke, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 700-700
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG
Gergely Tibor Kozma, Tamás Mészáros, Petra Berényi, et al.
Vaccine (2023) Vol. 41, Iss. 31, pp. 4561-4570
Open Access | Times Cited: 45
Humoral immune response after different SARS-CoV-2 vaccination regimens
Ruben Rose, Franziska Neumann, Olaf Grobe, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 57
Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference
Marianne Graninger, Claudia Jani, Elisabeth Reuberger, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 25
The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccination
Carina Saggau, Gabriela Rios Martini, Elisa Rosati, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1924-1939.e5
Open Access | Times Cited: 32
Progress in Electrochemical Biosensing of SARS-CoV-2 Virus for COVID-19 Management
Md. Mahbubur Rahman
Chemosensors (2022) Vol. 10, Iss. 7, pp. 287-287
Open Access | Times Cited: 31
Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
Carmen W. E. Embregts, Babs E. Verstrepen, Jan A. M. Langermans, et al.
One Health (2021) Vol. 13, pp. 100313-100313
Open Access | Times Cited: 37
Safety and Immunogenicity of SARS-CoV-2 vaccines in people with HIV
Manuel González de Aledo, Angelina Cañizares, Pilar Vázquez‐Rodríguez, et al.
AIDS (2022) Vol. 36, Iss. 5, pp. 691-695
Open Access | Times Cited: 25
Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination – kinetics of plasma antibodies, plasmablasts and memory B cells
Kilian A. Wietschel, Kevin Fechtner, Elmer Antileo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay
Minjeong Nam, Jong Do Seo, Hee‐Won Moon, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 29
The long term vaccine‐induced anti‐SARS‐CoV‐2 immune response is impaired in quantity and quality under TNFα blockade
Ulf Geisen, Ruben Rose, Franziska Neumann, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5780-5789
Open Access | Times Cited: 20
Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management
Ronald von Possel, Babett Menge, Christina Deschermeier, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 91-91
Open Access | Times Cited: 3
High avidity of vaccine-induced immunoglobulin G against SARS-CoV-2: potential relevance for protective humoral immunity
Georg Bauer
Exploration of Immunology (2022), pp. 133-156
Open Access | Times Cited: 16
Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2
Giacomo Malipiero, Pierlanfranco D’Agaro, Ludovica Segat, et al.
Clinica Chimica Acta (2021) Vol. 524, pp. 11-17
Open Access | Times Cited: 22
Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone
Eveline Santos da Silva, Michel Kohnen, Georges Gilson, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7675-7675
Open Access | Times Cited: 12
Differential avidity determination of IgG directed towards the receptor‐binding domain (RBD) of SARS‐CoV‐2 wild‐type and its variants in one assay: Rational tool for the assessment of protective immunity
Georg Bauer, Friedhelm Struck, Eva Staschik, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5294-5303
Open Access | Times Cited: 9
Vaccine Type-, Age- and Past Infection-Dependence of the Humoral Response to SARS-CoV-2 Spike S Protein
Salvador Romero-Pinedo, Marina Quesada, Lydia Horndler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Enzyme-Linked Immunosorbent Assay: An Adaptable Methodology to Study SARS-CoV-2 Humoral and Cellular Immune Responses
Amanda Izeli Portilho, Gabrielle Gimenes Lima, Elizabeth De Gaspari
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1503-1503
Open Access | Times Cited: 8
Longitudinal survey of humoral and cellular response to SARS-CoV-2 infection in children
Alba Ruedas-López, Arantxa Berzosa, Marta Illán Ramos, et al.
Microbiological Research (2022) Vol. 264, pp. 127145-127145
Open Access | Times Cited: 6
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions and immunogenicity of PEG-containing Covid-19 vaccines
Gergely Tibor Kozma, Tamás Mészáros, Petra Berényi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chattogram Metropolitan Area, Bangladesh
Jahan Ara, Md. Sirazul Islam, Md. Tarek Ul Quader, et al.
Antibodies (2022) Vol. 11, Iss. 4, pp. 69-69
Open Access | Times Cited: 5
Covid-19 vaccines elicit effective IgG responses in an elderly thymus cancer patient with chemotherapy
Ákos Koller, János Szebeni
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Sero-prevalence of anti-SARS-CoV-2 antibodies in Chattogram Metropolitan Area, Bangladesh
Jahan Ara, Md. Sirazul Islam, Md. Tarek Ul Quader, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
The anti-SARS-CoV-2 immunoglobulin G levels and neutralising capacities against alpha and delta virus variants of concern achieved after initial immunisation with vector vaccine followed by mRNA vaccine boost are comparable to those after double immunisation with mRNA vaccines
Ruben Rose, Franziska Neumann, Olaf Grobe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 5
In vitro Neutralization Effect of SARS-CoV-2 Specific IgG Against Delta and Omicron Variants of COVID-19 Virus Using Vero E6 Cells
Purwati Purwati, Nora Ertanti, Deya Karsari, et al.
Research Square (Research Square) (2024)
Closed Access
Evaluation of humoral immune response after ChAdOx1 nCoV‐19 vaccination among health care workers
Myeong Hee Kim, So Young Kang, Woo In Lee, et al.
Scandinavian Journal of Immunology (2023) Vol. 98, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top